Neoadjuvant chemoradiotherapy for resectable oesophageal cancer
Author:
Funder
Dutch Cancer Foundation
Netherlands Organisation for Health Research and Development
Publisher
Elsevier BV
Subject
Gastroenterology
Reference60 articles.
1. Epidemiology of esophageal cancer;Zhang;World J Gastroenterol,2013
2. Transthoracic versus transhiatal resection for carcinoma of the esophagus: a meta-analysis;Hulscher;Ann Thorac Surg,2001
3. Omloo JM, Lagarde SM, Hulscher JB, Reitsma JB, Fockens P, van Dekken H, et al. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the mid/distal esophagus: five-year survival of a randomized clinical trial. Ann Surg. 2007;246(6):992-1000; discussion -1.
4. Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial;Shapiro;Lancet Oncol,2015
5. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus;Hulscher;N Engl J Med,2002
Cited by 16 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Pathological response to neoadjuvant chemoradiotherapy for oesophageal squamous cell carcinoma in Eastern versus Western countries: meta-analysis;British Journal of Surgery;2024-05
2. Characteristics Predicting Short-Term and Long-Term Health-Related Quality of Life in Patients with Esophageal Cancer After Neoadjuvant Chemoradiotherapy and Esophagectomy;Annals of Surgical Oncology;2023-08-16
3. Radiomic applications in upper gastrointestinal cancer surgery;Langenbeck's Archives of Surgery;2023-06-06
4. Predictive Value of 18F-FDG PET/CT for Assessment of Tumor Response to Neoadjuvant Chemotherapy in Bladder Cancer;Clinical Nuclear Medicine;2023-03-26
5. RIG-I Promotes Tumorigenesis and Confers Radioresistance of Esophageal Squamous Cell Carcinoma by Regulating DUSP6;International Journal of Molecular Sciences;2023-03-15
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3